ONHS Report: HT942526MBRPTTDA

DoW Military Burn, Technology/Therapeutic Development Award

Solicitation ID: HT942526MBRPTTDA

Agency: DHA

Type: Cooperative Agreement

Deadline: 2026-10-21T00:00:00 ET

Eligibility: Yes (Team Member)

Funding: Approximately $5M is expected to fund three awards, with total cost caps of $1.6M for the Single PI option or $1.8M for the TTDA Mentorship Option.

Doc Type: BAA

Clearance: No

Program Manager: help@eBRAP.org

Last Updated: 2026-08-19 14:54

Analyzed File: HT942526MBRPTTDA_GG.pdf

Eligibility Reasoning

Federally Funded Research and Development Centers (FFRDCs) are not eligible to directly receive awards under this Broad Agency Announcement (BAA). However, teaming arrangements between FFRDCs and eligible organizations are allowed as long as they are permitted under the sponsoring agreement between the federal government and the specific FFRDC.

Note: This is an AI-generated summary...

Summary

The Fiscal Year 2026 (FY26) Military Burn Research Program (MBRP) offers the Technology/Therapeutic Development Award (TTDA) to support the translation of promising preclinical findings into burn care products for use in austere, resource-limited military operational environments. This product-driven award requires proposed technologies (e.g., medical devices, drugs, biologics, or knowledge products) to have achieved a minimum Technology Readiness Level (TRL) of 4 and address specific focus areas such as cold injury, complications from burn injuries (e.g., sepsis, inhalation injury), or interventions to mitigate chronic pain. A new Mentorship Option is available to foster junior researchers. The award prohibits clinical trials and enrollment of human subjects. Funding is capped at $1.6M for a single PI or $1.8M for the Mentorship Option over a maximum 3-year performance period.

Overall Technical Areas

Cold Injury TherapeuticsAcute Burn Care InnovationBurn Complication MitigationFluid Resuscitation ManagementBurn-Related Sepsis TreatmentInhalation Injury TreatmentPost-Burn Chronic Pain MitigationPreclinical Model ValidationPharmacokinetic & ADME-Tox StudiesIND/IDE Enabling StudiesMedical Device DevelopmentGMP Manufacturing ProcessesProduct Stability & Shelf-Life StudiesBiostatistical Analysis & Study Design

Probable LBNL Areas

N/A

Focus Areas

Example Priorities:

Development and/or validation of methods to triage, treat, and/or prevent complications of cold injury.
Research to innovate best practices in the acute burn care continuum in a combat setting.
Development and/or validation of methods for use in a combat setting to prevent, assess, and/or treat burn injury-related complications, including: Over/under fluid resuscitation, Endotheliopathy, Sepsis, Inhalation injuries, Fungal infections, Hypermetabolism.
Interventions applied during the early, acute phase of burn injury that prevent or mitigate later development of chronic pain, neuropathy, pruritus and temperature dysregulation.

Specific Technical Skills:

Development and/or validation of methods to triage, treat, and/or prevent complications of cold injury.Research to innovate best practices in the acute burn care continuum in a combat setting.Development and/or validation of methods for use in a combat setting to prevent, assess, and/or treat burn injury-related complications, including: Over/under fluid resuscitation, Endotheliopathy, Sepsis, Inhalation injuries, Fungal infections, Hypermetabolism.Interventions applied during the early, acute phase of burn injury that prevent or mitigate later development of chronic pain, neuropathy, pruritus and temperature dysregulation.

Potential PIs for this Area:

Name	Score	Organization

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

Name	Score	Organization
Peter Tennessen	0.73	PSA \| Engineering \| Mechanical Engineering · Medical Device Development
Yan Chen	0.72	BSA \| Biological Systems & Engineering \| Process Engr & Analytics · GMP Manufacturing Processes
Jennifer Rosenbluth	0.72	· Preclinical Model Validation
Thomas Hendrickson	0.71	ETA \| Energy Analysis \| Systems & Energy Tech Analysis · Product Stability & Shelf-Life Studies
Natalia Molchanova	0.71	ESA \| MF \| MF Biological Facility · Pharmacokinetic & ADME-Tox Studies
Michelle O'Malley	0.70	BSA \| Biological Systems & Engineering \| Biodesign Dept · Acute Burn Care Innovation
Jamie Inman	0.70	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · IND/IDE Enabling Studies
Minok Park	0.70	ETA \| ESDR \| Energy Storage & Dist Dpt · Burn Complication Mitigation
Zixi Hu	0.70	CSA \| AMCR \| Mathematics · Biostatistical Analysis & Study Design
Gerard Marriott	0.70	BSA \| Molecular Biophysics & Integrated Bioimaging \| Cellular & Tissue Image · Cold Injury Therapeutics

Fundamental Research Exemption (FRE)

In accordance with National Security Presidential Memorandum-33 and all associated laws, all fundamental research funded by the DOW must be evaluated for affiliations with foreign entities.